Live Breaking News & Updates on Fast track initiative

Stay updated with breaking news from Fast track initiative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

United-states , San-antonio , Texas , Chicago , Illinois , Cambridge , Cambridgeshire , United-kingdom , American , Justin-moser , Jordi-rodon-ahnert , Kyriakos-papadopoulos

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , California , Cambridge , Cambridgeshire , United-kingdom , San-diego , Babraham , American , Alexandra-sapetschnig , Matthew-fyfe , Natalie-webster , Konstantinos-tzelepis

STORM Therapeutics To Present Data On Its First-In-Class METTL1 Trna Methyltransferase Inhibitors At AACR Annual Meeting 2024

STORM Therapeutics To Present Data On Its First-In-Class METTL1 Trna Methyltransferase Inhibitors At AACR Annual Meeting 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Cambridge , Cambridgeshire , Babraham , San-diego , California , American , Sarah-bucknell , Konstantinos-tzelepis , Jack-rogan , Alexandra-sapetschnig

STORM Therapeutics Ltd: STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

STORM Therapeutics Ltd: STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , California , Babraham , Cambridgeshire , United-kingdom , San-diego , Cambridge , American , Harry-fischl , Oliver-rausch , Byron-andrews , Dennis-riedl

STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress

STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , United-kingdom , France , Cambridge , Cambridgeshire , Babraham , Paris , France-general- , Lesen , Aquitaine , Sarah-bucknell , Harry-fischl

peacecorpsconnect.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from peacecorpsconnect.org Daily Mail and Mail on Sunday newspapers.

Florida , United-states , Rockport , Ohio , Liberia , Samoa , Guinea , Chad , Guatemala , Turkey , California , Thailand

Latest biotech news: fundraises, deals, clinical trials

What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

Denmark , Chicago , Illinois , United-states , South-korea , Massachusetts , Alexandria , Al-iskandariyah , Egypt , Netherlands , Japan , France

Shinobi Therapeutics Raises $51M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Japan , California , United-states , San-francisco , Kyoto , Dan-kemp , Shin-kaneko , Tobias-deuse , Life-sciences , University-of-california , Kyoto-university , Fast-track-initiative

STORM Therapeutics' First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference

STORM Therapeutics' First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , San-diego , California , Jerry-mcmahon , Konstantinos-tzelepis , Principal-investigator-at-university-of-cambridge , University-of-cambridge , Ip-group , Cambridge-stem-cell-institute

STORM Therapeutics' First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule therapies targeting...

United-states , San-diego , California , Cambridge , Cambridgeshire , United-kingdom , Jerry-mcmahon , Konstantinos-tzelepis , Cambridge-stem-cell-institute , Principal-investigator-at-university-of-cambridge , University-of-cambridge , Therapeutics-ltd